According to a new report from Intel Market Research, the global BioMEMS market was valued at USD 3.2 billion in 2025 and is projected to reach USD 7.8 billion by 2034, growing at a robust CAGR of 10.2 % during the forecast period (2026–2034). This expansion is driven by the rising demand for portable diagnostic platforms, rapid advances in personalized medicine, and heightened...

According to a newly published market research report by 24LifeSciences, the global Bluetooth blood glucose meter market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.8 billion by 2032, growing at a compound annual growth rate (CAGR) of 10.5% during the forecast period 2025–2032. A Bluetooth blood glucose meter is an advanced medical device designed...

The report "Diabetes Care Devices Market by Product Type (Blood Glucose Monitoring (CGM), Insulin Delivery Devices (Insulin Pumps (Tethered), Insulin Pens, Pen Needles), Application), Disease Type (Type 1, Type 2), End User (Homecare/Self) - Global Forecast to 2030", is projected to reach 61.2 billion in 2030 from USD 34.3 billion in 2025, at a CAGR of 12.3% during the forecast...

Diabetes testing systems are foundational to effective disease management, enabling timely diagnosis, continuous glucose tracking, and informed therapeutic decision-making. Their importance within the healthcare and life sciences ecosystem continues to grow as healthcare systems worldwide shift toward preventive care, patient-centric monitoring, and data-driven disease management strategies....

According to a new report from Intel Market Research, the global Biosensor Semiconductor market was valued at USD 4.12 billion in 2025 and is projected to reach USD 8.73 billion by 2034, growing at a robust CAGR of 7.3% during the forecast period (2026–2034). This expansion is driven by the accelerating demand for point‑of‑care diagnostics, the rise of wearable health‑monitoring devices,...

 According to a newly published market research report by 24LifeSciences, global glycated hemoglobin testing market was valued at USD 322 million in 2024 and is projected to reach USD 530 million by 2031, growing at a compound annual growth rate (CAGR) of 7.6% during the forecast period 2025-2031. Glycated hemoglobin (HbA1c) testing serves as...

According to a newly published market research report by 24LifeSciences, global glycated hemoglobin testing market was valued at USD 322 million in 2024 and is projected to reach USD 530 million by 2031, growing at a compound annual growth rate (CAGR) of 7.6% during the forecast period 2025-2031. Glycated hemoglobin (HbA1c) testing serves as the gold standard for diabetes management...